Meeting Abstract

Targeted next generation sequencing is a universal tool for non-invasive diagnosis of fetal platelet antigens in fetal and neonatal alloimmune thrombocytopenia


AutorenlisteWienzek-Lischka, S.; Froehner, V; Krautwurst, A.; Dehl, J.; Gattenloehner, S.; Braeuninger, A.; Deisting, C.; Axt-Fliedner, R.; Degenhardt, J.; Santoso, S.; Sachs, U.; Bein, G.

Jahr der Veröffentlichung2017

Seiten2-2

ZeitschriftTransfusion Medicine and Hemotherapy

Bandnummer44

ISSN1660-3796

eISSN1660-3818

VerlagKarger Publishers



Zitierstile

Harvard-ZitierstilWienzek-Lischka, S., Froehner, V., Krautwurst, A., Dehl, J., Gattenloehner, S., Braeuninger, A., et al. (2017) Targeted next generation sequencing is a universal tool for non-invasive diagnosis of fetal platelet antigens in fetal and neonatal alloimmune thrombocytopenia, Transfusion Medicine and Hemotherapy, 44, p. 2

APA-ZitierstilWienzek-Lischka, S., Froehner, V., Krautwurst, A., Dehl, J., Gattenloehner, S., Braeuninger, A., Deisting, C., Axt-Fliedner, R., Degenhardt, J., Santoso, S., Sachs, U., & Bein, G. (2017). Targeted next generation sequencing is a universal tool for non-invasive diagnosis of fetal platelet antigens in fetal and neonatal alloimmune thrombocytopenia. Transfusion Medicine and Hemotherapy. 44, 2.


Zuletzt aktualisiert 2025-21-05 um 18:14